{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:38:25Z","timestamp":1792726705689,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":123,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akdh.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.akdh.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:26:13Z","timestamp":1787225173000},"page":"129-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When the Bottle Lies: Advances in Detecting Medication Adherence in Hypertension"],"prefix":"10.1053","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-5974","authenticated-orcid":false,"given":"Januvi","family":"Jegatheswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7448-2677","authenticated-orcid":false,"given":"Indranil","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.akdh.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/39.10.1940308","article-title":"Thrombospondin: a component of microfibrils in various tissues","volume":"39","author":"Arbeille","year":"1991","journal-title":"J Histochem Cytochem"},{"key":"10.1053\/j.akdh.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","article-title":"Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories","volume":"52","author":"Blaschke","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"17","key":"10.1053\/j.akdh.2026.06.006_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026582","article-title":"Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1053\/j.akdh.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/HJH.0000000000001299","article-title":"Drug adherence in hypertension: from methodological issues to cardiovascular outcomes","volume":"35","author":"Hamdidouche","year":"2017","journal-title":"J Hypertens"},{"issue":"7","key":"10.1053\/j.akdh.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"key":"10.1053\/j.akdh.2026.06.006_bib6","series-title":"Adherence to long-term therapies: evidence for action","year":"2003"},{"issue":"6","key":"10.1053\/j.akdh.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"issue":"7653","key":"10.1053\/j.akdh.2026.06.006_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.akdh.2026.06.006_bib9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/HJH.0000000000002398","article-title":"Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals","volume":"38","author":"Lawson","year":"2020","journal-title":"J Hypertens"},{"issue":"6","key":"10.1053\/j.akdh.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"key":"10.1053\/j.akdh.2026.06.006_bib11","article-title":"Poor adherence to antihypertensive drugs","volume":"354","author":"Hameed","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"10.1053\/j.akdh.2026.06.006_bib12","first-page":"568","article-title":"Antihypertensive medication adherence and subsequent healthcare utilization and costs","volume":"16","author":"Pittman","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1053\/j.akdh.2026.06.006_bib13","series-title":"Evaluation of the scale, causes and costs of waste medicines. Report of DH funded national project","author":"Trueman","year":"2010"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10198-013-0554-4","article-title":"Cost of poor adherence to anti-hypertensive therapy in five European countries","volume":"16","author":"Mennini","year":"2015","journal-title":"Eur J Health Econ"},{"key":"10.1053\/j.akdh.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1472-6963-12-270","article-title":"Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss","volume":"12","author":"Meddings","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"10.1053\/j.akdh.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/HJH.0000000000001502","article-title":"Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis","volume":"35","author":"Durand","year":"2017","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/08037051.2022.2104215","article-title":"Clinical characteristics do not reliably identify non-adherence in patients with uncontrolled hypertension","volume":"31","author":"Groenland","year":"2022","journal-title":"Blood Press"},{"issue":"3","key":"10.1053\/j.akdh.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bcp.12194","article-title":"What are validated self-report adherence scales really measuring?: a systematic review","volume":"77","author":"Nguyen","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1053\/j.akdh.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/clpt.2014.59","article-title":"Methods for measuring, enhancing, and accounting for medication adherence in clinical trials","volume":"95","author":"Vrijens","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1053\/j.akdh.2026.06.006_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11906-015-0579-4","article-title":"Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension","volume":"17","author":"Ruzicka","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1053\/j.akdh.2026.06.006_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF03256649","article-title":"The role of DOTS in tuberculosis treatment and control","volume":"2","author":"Davies","year":"2003","journal-title":"Am J Respir Med"},{"issue":"10","key":"10.1053\/j.akdh.2026.06.006_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamainternmed.2019.1455","article-title":"Use of directly observed therapy to assess treatment adherence in patients with apparent treatment-resistant hypertension","volume":"179","author":"Ruzicka","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1053\/j.akdh.2026.06.006_bib23","first-page":"1741.e1","article-title":"Adherence to blood pressure-lowering drugs and resistant hypertension: should trial of direct observation therapy be part of preassessment for renal denervation?","volume":"29","author":"Ruzicka","year":"2013","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1053\/j.akdh.2026.06.006_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/jhh.2015.38","article-title":"Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic","volume":"30","author":"Hameed","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1053\/j.akdh.2026.06.006_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/jhh.2010.108","article-title":"How common is true resistant hypertension?","volume":"25","author":"Bunker","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1053\/j.akdh.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2014.10.162","article-title":"Witnessed drug intake before planned denervation--always harmless?","volume":"179","author":"Linicus","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.akdh.2026.06.006_bib27","series-title":"Drug Adherence in Hypertension and Cardiovascular Protection. Updates in Hypertension and Cardiovascular Protection","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-76593-8_6","article-title":"Directly observed therapy in hypertension (DOT-HTN)","author":"Hj\u00f8rnholm","year":"2018"},{"issue":"3","key":"10.1053\/j.akdh.2026.06.006_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/08037051.2019.1599814","article-title":"Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study","volume":"28","author":"Wunder","year":"2019","journal-title":"Blood Press"},{"key":"10.1053\/j.akdh.2026.06.006_bib29","series-title":"Drug Adherence in Hypertension and Cardiovascular Protection. Updates in Hypertension and Cardiovascular Protection","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-76593-8_4","article-title":"Measurements of antihypertensive medications in blood and urine","author":"Gupta","year":"2018"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.121.17596","article-title":"Nonadherence in hypertension: how to develop and implement chemical adherence testing","volume":"79","author":"Lane","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.120.16061","article-title":"Plasma trough concentrations of antihypertensive drugs for the assessment of treatment adherence: a meta-analysis","volume":"77","author":"Groenland","year":"2021","journal-title":"Hypertension"},{"key":"10.1053\/j.akdh.2026.06.006_bib32","doi-asserted-by":"crossref","DOI":"10.2196\/57652","article-title":"Medication management initiatives using wearable devices: scoping review","volume":"11","author":"Iino","year":"2024","journal-title":"JMIR Hum Factors"},{"key":"10.1053\/j.akdh.2026.06.006_bib33","article-title":"Detection of medication taking using a wrist-worn commercially available wearable device","volume":"7","author":"Laughlin","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1053\/j.akdh.2026.06.006_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.artmed.2016.03.004","article-title":"A wearable sensor system for medication adherence prediction","volume":"69","author":"Kalantarian","year":"2016","journal-title":"Artif Intell Med"},{"key":"10.1053\/j.akdh.2026.06.006_bib35","series-title":"Addressing Patient Nonadherence","author":"Adedeji","year":"2024"},{"issue":"10","key":"10.1053\/j.akdh.2026.06.006_bib36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajh\/hpae059","article-title":"Effect of therapeutic drug monitoring on adherence and blood pressure: a multicenter randomized clinical trial","volume":"37","author":"Halvorsen","year":"2024","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1053\/j.akdh.2026.06.006_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.akdh.2026.06.006_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/ijcp.12591","article-title":"Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker\/thiazide diuretics among newly diagnosed hypertensive patients: a population-based cohort study","volume":"69","author":"Hsu","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"12","key":"10.1053\/j.akdh.2026.06.006_bib39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2146\/ajhp060434","article-title":"Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents","volume":"64","author":"Gerbino","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/2013.jamainternmed.717","article-title":"Automated outreach to increase primary adherence to cholesterol-lowering medications","volume":"173","author":"Derose","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1053\/j.akdh.2026.06.006_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"issue":"13","key":"10.1053\/j.akdh.2026.06.006_bib42","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2024.18080","article-title":"Low-dose triple-pill vs standard-care protocols for hypertension treatment in Nigeria: a randomized clinical trial","volume":"332","author":"Ojji","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1377\/hlthaff.2017.0881","article-title":"Medication synchronization programs improve adherence to cardiovascular medications and health care use","volume":"37","author":"Krumme","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"suppl 1","key":"10.1053\/j.akdh.2026.06.006_bib44","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00126097-200005001-00006","article-title":"Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension","volume":"5","author":"Burnier","year":"2000","journal-title":"Blood Press Monit"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0277-9536(91)90132-V","article-title":"Patient compliance--whose responsibility?","volume":"32","author":"Ross","year":"1991","journal-title":"Soc Sci Med"},{"issue":"3 Pt 1","key":"10.1053\/j.akdh.2026.06.006_bib46","first-page":"266","article-title":"[Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications]","volume":"28","author":"Misdrahi","year":"2002","journal-title":"Encephale"},{"issue":"22","key":"10.1053\/j.akdh.2026.06.006_bib47","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.288.22.2868","article-title":"Interventions to enhance patient adherence to medication prescriptions: scientific review","volume":"288","author":"McDonald","year":"2002","journal-title":"JAMA"},{"issue":"12","key":"10.1053\/j.akdh.2026.06.006_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11906-020-01115-4","article-title":"Strategies to improve adherence to anti-hypertensive medications: a narrative review","volume":"22","author":"Izeogu","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1053\/j.akdh.2026.06.006_bib49","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYP.0000000000000203","article-title":"Medication adherence and blood pressure control: a scientific statement from the American Heart Association","volume":"79","author":"Choudhry","year":"2022","journal-title":"Hypertension"},{"issue":"10","key":"10.1053\/j.akdh.2026.06.006_bib50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/ajh\/hpv008","article-title":"The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis","volume":"28","author":"Fletcher","year":"2015","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1053\/j.akdh.2026.06.006_bib51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.2014.10059","article-title":"Electronic medication packaging devices and medication adherence: a systematic review","volume":"312","author":"Checchi","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1053\/j.akdh.2026.06.006_bib52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCULATIONAHA.116.022922","article-title":"Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial","volume":"134","author":"Azizi","year":"2016","journal-title":"Circulation"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:00:43Z","timestamp":1792724443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813926000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2949813926000790"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2026.06.006","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When the Bottle Lies: Advances in Detecting Medication Adherence in Hypertension","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}